Altered Volume, Morphology and Composition of the Pancreas in Type 2 Diabetes

Objective Although impairment in pancreatic insulin secretion is known to precede the clinical diagnosis of type 2 diabetes by up to a decade, fasting blood glucose concentration only rises abnormally once the impairment reaches a critical threshold. Despite its centrality to the pathogenesis of type 2 diabetes, the pancreas is the least studied organ due to its inaccessible anatomical position. Previous ultrasound and CT studies have suggested a possible decrease in pancreatic volume in type 2 diabetes. However, ultrasound techniques are relatively insensitive while CT uses ionizing radiation, making these modalities unsuitable for precise, longitudinal studies designed to explore the underlying mechanisms of type 2 diabetes. Hence there is a need to develop a non-invasive, safe and precise method to quantitate pancreas volume. Methods We developed and applied magnetic resonance imaging at 3.0T to obtain balanced turbo field echo (BTFE) structural images of the pancreas, together with 3-point Dixon images to quantify pancreatic triglyceride content. Pancreas volume, morphology and triglyceride content was quantified in a group of 41 subjects with well-controlled type 2 diabetes (HbA1c ≤ 7.6%) taking only metformin (duration of T2DM 5.7±0.7years), and a control group of 14 normal glucose tolerance subjects matched for age, weight and sex. Results The mean pancreatic volume was found to be 33% less in type 2 diabetes than in normal glucose tolerant subjects (55.5±2.8 vs. 82.6±4.8cm3; p<0.0001). Pancreas volume was positively correlated with HOMA-β in the type 2 diabetes subjects (r = 0.31; p = 0.03) and controls (r = 0.46; p = 0.05) considered separately; and in the whole population studied (r = 0.37; p = 0.003). In type 2 diabetes, the pancreas was typically involuted with a serrated border. Pancreatic triglyceride content was 23% greater (5.4±0.3 vs. 4.4±0.4%; p = 0.02) in the type 2 diabetes group. Conclusion This study describes for the first time gross abnormalities of the pancreas in early type 2 diabetes and quantifies the decrease in pancreas size, the irregular morphology and increase in fat content.

[1]  R. Taylor,et al.  Restoring normoglycaemia by use of a very low calorie diet in long‐ and short‐duration Type 2 diabetes , 2015, Diabetic medicine : a journal of the British Diabetic Association.

[2]  Roy Taylor,et al.  Effect of Vildagliptin on Hepatic Steatosis , 2015, The Journal of clinical endocrinology and metabolism.

[3]  J. Florez,et al.  Differences in pancreatic volume, fat content, and fat density measured by multidetector-row computed tomography according to the duration of diabetes , 2014, Acta Diabetologica.

[4]  Ming-Fong Chen,et al.  The Association between Nonalcoholic Fatty Pancreas Disease and Diabetes , 2013, PloS one.

[5]  Edward W. Szczepaniak,et al.  Measurement of Pancreatic Volume by Abdominal MRI: A Validation Study , 2013, PloS one.

[6]  R. Bergman,et al.  Pancreatic Steatosis and Its Relationship to β-Cell Dysfunction in Humans , 2012, Diabetes Care.

[7]  C. Dayan,et al.  Pancreatic volume is reduced in adult patients with recently diagnosed type 1 diabetes. , 2012, The Journal of clinical endocrinology and metabolism.

[8]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[9]  Benjamin S. Aribisala,et al.  Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol , 2011, Diabetologia.

[10]  C. Cobelli,et al.  Ongoing β-Cell Turnover in Adult Nonhuman Primates Is Not Adaptively Increased in Streptozotocin-Induced Diabetes , 2011, Diabetes.

[11]  R. Taylor,et al.  Dietary reversal of Type 2 diabetes motivated by research knowledge , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[12]  Mika Kivimäki,et al.  Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study , 2009, The Lancet.

[13]  Claudio Cobelli,et al.  Primary Defects in β-Cell Function Further Exacerbated by Worsening of Insulin Resistance Mark the Development of Impaired Glucose Tolerance in Obese Adolescents , 2009, Diabetes Care.

[14]  C. Sempoux,et al.  Pancreatic β‐cell mass in European subjects with type 2 diabetes , 2008, Diabetes, obesity & metabolism.

[15]  P. Pouwels,et al.  Pancreatic Fat Content and β-Cell Function in Men With and Without Type 2 Diabetes , 2007, Diabetes Care.

[16]  C. Cobelli,et al.  Acute inhibition of lipolysis does not affect postprandial suppression of endogenous glucose production. , 2005, American journal of physiology. Endocrinology and metabolism.

[17]  A. Bagust,et al.  Deteriorating beta-cell function in type 2 diabetes: a long-term model. , 2003, QJM : monthly journal of the Association of Physicians.

[18]  Robert A. Rizza,et al.  β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.

[19]  R. Holman,et al.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.

[20]  D. Altman,et al.  Comparing methods of measurement: why plotting difference against standard method is misleading , 1995, The Lancet.

[21]  A Alzaid,et al.  The Size of the Pancreas in Diabetes Mellitus , 1993, Diabetic medicine : a journal of the British Diabetic Association.

[22]  G H Glover,et al.  Three‐point dixon technique for true water/fat decomposition with B0 inhomogeneity correction , 1991, Magnetic resonance in medicine.

[23]  D. DuBois,et al.  A formula to estimate the approximate surface area if height and weight be known , 1989 .

[24]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[25]  G. Reaven.  Banting lecture 1988. Role of insulin resistance in human disease. , 1988, Diabetes.

[26]  R. Turner,et al.  Natural History of Pancreatic Islet B‐Cell Function in Type 2 Diabetes Mellitus Studied over Six Years by Homeostasis Model Assessment , 1988, Diabetic medicine : a journal of the British Diabetic Association.

[27]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[28]  B. Frier,et al.  Pancreatic Endocrine—Exocrine Function in Diabetes: An Old Alliance Disturbed , 1984, Diabetic medicine : a journal of the British Diabetic Association.

[29]  B V Howard,et al.  Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. , 1984, The Journal of clinical investigation.

[30]  Y. Le Marchand-Brustel,et al.  Effects and binding of insulin-like growth factor I in the isolated soleus muscle of lean and obese mice: comparison with insulin. , 1979, Endocrinology.

[31]  L. Kreel,et al.  Computed Tomography of the Normal Pancreas , 1977, Journal of computer assisted tomography.

[32]  D. D. Bois,et al.  CLINICAL CALORIMETRY: TENTH PAPER A FORMULA TO ESTIMATE THE APPROXIMATE SURFACE AREA IF HEIGHT AND WEIGHT BE KNOWN , 1916 .

[33]  R. Bergman,et al.  Pancreatic Steatosis and Its Relationship to b-Cell Dysfunction in Humans Racial and ethnic variations , 2012 .

[34]  Victor Couture,et al.  Appendix for online publication , 2007 .

[35]  M. Reiser,et al.  Age-related morphology of the normal pancreas on computed tomography , 2005, Gastrointestinal Radiology.

[36]  S. Haffner,et al.  Mode of onset of type 2 diabetes from normal or impaired glucose tolerance. , 2004, Diabetes.

[37]  C. Osmond,et al.  Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth , 2004, Diabetologia.

[38]  Robert A Rizza,et al.  Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. , 2003, Diabetes.

[39]  合田 公志.  Pancreatic volume in type 1 and type 2 diabetes mellitus , 2002 .

[40]  G. Reaven.  Banting lecture 1988 , 1997 .

[41]  I. Migdalis,et al.  Size of the pancreas in non-insulin-dependent diabetic patients. , 1991, Journal of medicine.